1989
DOI: 10.1080/00034983.1989.11812353
|View full text |Cite
|
Sign up to set email alerts
|

Efficacy of chloroquine in the treatment of malaria in children under five years in Baissa (Gongola State, Nigeria)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
5
0

Year Published

1990
1990
2005
2005

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 10 publications
(6 citation statements)
references
References 14 publications
1
5
0
Order By: Relevance
“…The present work has shown the effectiveness of a scheme using a single dose of chloroquine, comparable to the classical schemes. Similar results have been obtained in Asia and Africa 6,7 .…”
Section: Discussionsupporting
confidence: 88%
See 2 more Smart Citations
“…The present work has shown the effectiveness of a scheme using a single dose of chloroquine, comparable to the classical schemes. Similar results have been obtained in Asia and Africa 6,7 .…”
Section: Discussionsupporting
confidence: 88%
“…There is a possibility that, within a mean period of 20 days after beginning treatment, the patients present a limited parasitological recrudescence per si, without a manifest clinical picture. This phenomenon has been demonstrated byDANIEL & MOLTA (1989). They used a single dose of chloroquine in the treatment of 53 children, in which the failure of schizonticide action of chloroquine was demonstrated and this was not associated with clinical disease7 .…”
mentioning
confidence: 94%
See 1 more Smart Citation
“…Malaria is a disease of immense public importance. Available data suggest that there are 200-300 million cases, with more than two million deaths each year (Krogtad et al, 1990) out of which one million is from the African continent alone (Daniel and Molta, 1989). Chloroquine, a 4-aminoquinolone, has been the mainstay of malaria chemotherapy for almost 50 years now.…”
Section: Introductionmentioning
confidence: 99%
“…This is because of its rapid onset of action, low toxicity and, almost low expense. It has remained the cheapest and most widely used antimalarial drug in West Africa (Adubofour, 1992) and in Nigeria (Daniel and Molta, 1989). A WHO scientifc group has drawn the attention of the emergence of chloroquine-resistant Plasmodium falciparum in Sub -saharan Africa (WHO 1994).…”
Section: Introductionmentioning
confidence: 99%